logo
Select company
Select metric
$ -1.74MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
32
Sector
72
Industry
43
History
57
$ 1.82Close
$ 1.3 - $ 2.95 52-Week Range
Ticker Information

Ticker

CPHI

Company Name

CHINA PHARMA HOLDINGS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NYSEMKT

CHINA PHARMA HOLDINGS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CPHI - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1.8M$ -3.54M$ -1.74M
3/31/2025$ 2.21M$ -4.43M$ -2.21M
12/31/2024$ 2.62M$ -4.58M$ -1.96M
9/30/2024$ 2.87M$ -4.57M$ -1.7M
6/30/2024$ 2.85M$ -4.2M$ -1.35M
3/31/2024$ 2.81M$ -3.26M$ -454.86K
12/31/2023$ 2.75M$ -2.75M$ 8.44K
9/30/2023$ 2.7M$ -2.73M$ -34.02K
6/30/2023$ 2.68M$ -2.71M$ -28.22K
3/31/2023$ 2.67M$ -3.03M$ -362.83K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CHINA PHARMA HOLDINGS INC's latest trailing twelve months (TTM) EBITDA stands at $ -17.5M.
  • Over the past 5 years, CHINA PHARMA HOLDINGS INC's average EBITDA has been $ -1.45M.
  • The median EBITDA for CHINA PHARMA HOLDINGS INC during this period was $ -304.25K
  • CHINA PHARMA HOLDINGS INC reached its highest EBITDA over the past 5 years at $ 230.34K.
  • The lowest EBITDA recorded by CHINA PHARMA HOLDINGS INC in the same timeframe $ -17.5M

CHINA PHARMA HOLDINGS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
INM : INMED PHARMACEUTICALS INC $ -7.26MNBY : NOVABAY PHARMACEUTICALS INC $ 3.61MBNBX : APPLIED DNA SCIENCES INC $ -12.85MXBIO : XENETIC BIOSCIENCES INC $ -3.08MNAOV : NANOVIBRONIX INC $ -4.33MSHPH : SHUTTLE PHARMACEUTICALS HOLDINGS INC $ -11.83MISPC : ISPECIMEN INC $ -8.26MONCO : ONCONETIX INC $ -43.75MSPRB : SPRUCE BIOSCIENCES INC $ -45.81MWORX : SCWORX CORP $ -1.25M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for CHINA PHARMA HOLDINGS INC is calculated as follows: EBIT [ $ -20.15M ] + DepAmor [ $ 2.65M ]
(=) EBITDA [ $ -17.5M ]

CPHI - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -17.5M

Minimum

Sep 30, 2020

$ 230.34K

Maximum

Dec 31, 2021

$ -1.45M

Average

$ -304.25K

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M